Noor Momin, Ph.D.

Noor (she/her) seeks to extend immuno-engineering to the challenges of cardiovascular disease, autoimmunity and cancer. As a graduate student, Noor engineered a strategy that improves the safety and effectiveness of cytokine immunotherapies used for cancer treatment. Her patented technology is being used to treat pet dogs with oral melanoma and soft tissue sarcoma and has been licensed to Cullinan Oncology for human drug development. Noor is passionate about powering effective therapies that advance patient care and combat globally burdensome diseases. Outside the lab, Noor enjoys cooking cuisines from around the world.

CURRENT POSITION
University of Pennsylvania
Stephenson Foundation Term Assistant Professor of Innovation (2024 - present)
Department of Bioengineering, School of Engineering and Applied Science

Member, Center for Precision Engineering for Human Health (CPE4H)
Member, Center for Cellular Immunotherapies (CCI)
Member, Center for Targeted Therapeutics and Translational Nanomedicine
Member, Institute for Translational Medicine and Therapeutics
Member, Penn Cardiovascular Institute
Member, Penn Institute for Immunology
Member, Penn Institute for Regeneration Medicine

EDUCATION
Massachusetts General Hospital/Harvard University
Postdoctoral Fellow, 2021 - 2023

Massachusetts Institute of Technology
Ph.D., Biological Engineering, 2021

The University of Texas at Austin
BS, Biomedical Engineering, 2015